Immunohistochemistry staining of more than 200 clinical samples revealed that DDR1 was overexpressed in approximately 41% and 48% of the intestinal and diffuse types of GC cases, respectively, compared with only 3.5% in normal tissues. Here, DDR1 is linked to gastric cancer.